Home >  Investors Relations >  CryoLife to Present at Two Investor Conferences in September 2017

CryoLife to Present at Deutsche Bank 42nd Annual Health Care Conference

April 27, 2017 at 5:00 PM EDT

ATLANTA, April 27, 2017 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that it will participate in the upcoming Deutsche Bank 42nd Annual Health Care Conference on Wednesday, May 3, 2017 at the InterContinental Boston Hotel.

A live webcast of the Company's presentation is scheduled to begin at 8:00 a.m. ET and will feature an overview of the company by Pat Mackin, Chairman, President and Chief Executive Officer.  

The live webcast can be accessed through CryoLife's website, www.cryolife.com, on the Investor Relations page.  An archived copy of the webcast will be available for 90 days on the same website.

About CryoLife

Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of implantable living tissues and medical devices used in cardiac surgical procedures.  CryoLife markets and sells products in more than 80 countries worldwide.  For additional information about CryoLife, visit our website, www.cryolife.com.

Contacts:






CryoLife                                                          

The Ruth Group                    


D. Ashley Lee                                                    

Nick Laudico / Zack Kubow      


Executive Vice President, Chief Financial Officer    

646-536-7030 / 7020              


and Chief Operating Officer                                    

nlaudico@theruthgroup.com   


Phone: 770-419-3355                                            

zkubow@theruthgroup.com        


 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cryolife-to-present-at-deutsche-bank-42nd-annual-health-care-conference-300447365.html

SOURCE CryoLife, Inc.